574 related articles for article (PubMed ID: 20923787)
21. Ammonium accumulation and cell death in a rat 3D brain cell model of glutaric aciduria type I.
Jafari P; Braissant O; Zavadakova P; Henry H; Bonafé L; Ballhausen D
PLoS One; 2013; 8(1):e53735. PubMed ID: 23326493
[TBL] [Abstract][Full Text] [Related]
22. Glutaric acidemia type 1.
Hedlund GL; Longo N; Pasquali M
Am J Med Genet C Semin Med Genet; 2006 May; 142C(2):86-94. PubMed ID: 16602100
[TBL] [Abstract][Full Text] [Related]
23. Marked reduction of Na(+), K(+)-ATPase and creatine kinase activities induced by acute lysine administration in glutaryl-CoA dehydrogenase deficient mice.
Amaral AU; Cecatto C; Seminotti B; Zanatta Â; Fernandes CG; Busanello EN; Braga LM; Ribeiro CA; de Souza DO; Woontner M; Koeller DM; Goodman S; Wajner M
Mol Genet Metab; 2012 Sep; 107(1-2):81-6. PubMed ID: 22578804
[TBL] [Abstract][Full Text] [Related]
24. Intracerebral accumulation of glutaric and 3-hydroxyglutaric acids secondary to limited flux across the blood-brain barrier constitute a biochemical risk factor for neurodegeneration in glutaryl-CoA dehydrogenase deficiency.
Sauer SW; Okun JG; Fricker G; Mahringer A; Müller I; Crnic LR; Mühlhausen C; Hoffmann GF; Hörster F; Goodman SI; Harding CO; Koeller DM; Kölker S
J Neurochem; 2006 May; 97(3):899-910. PubMed ID: 16573641
[TBL] [Abstract][Full Text] [Related]
25. Toxic synergism between quinolinic acid and organic acids accumulating in glutaric acidemia type I and in disorders of propionate metabolism in rat brain synaptosomes: Relevance for metabolic acidemias.
Colín-González AL; Paz-Loyola AL; Serratos I; Seminotti B; Ribeiro CA; Leipnitz G; Souza DO; Wajner M; Santamaría A
Neuroscience; 2015 Nov; 308():64-74. PubMed ID: 26343296
[TBL] [Abstract][Full Text] [Related]
26. Acute lysine overload provokes protein oxidative damage and reduction of antioxidant defenses in the brain of infant glutaryl-CoA dehydrogenase deficient mice: a role for oxidative stress in GA I neuropathology.
Seminotti B; Ribeiro RT; Amaral AU; da Rosa MS; Pereira CC; Leipnitz G; Koeller DM; Goodman S; Woontner M; Wajner M
J Neurol Sci; 2014 Sep; 344(1-2):105-13. PubMed ID: 24996493
[TBL] [Abstract][Full Text] [Related]
27. Characterization and structure of the human lysine-2-oxoglutarate reductase domain, a novel therapeutic target for treatment of glutaric aciduria type 1.
Leandro J; Khamrui S; Suebsuwong C; Chen PJ; Secor C; Dodatko T; Yu C; Sanchez R; DeVita RJ; Houten SM; Lazarus MB
Open Biol; 2022 Sep; 12(9):220179. PubMed ID: 36128717
[TBL] [Abstract][Full Text] [Related]
28. Biochemistry and bioenergetics of glutaryl-CoA dehydrogenase deficiency.
Sauer SW
J Inherit Metab Dis; 2007 Oct; 30(5):673-80. PubMed ID: 17879145
[TBL] [Abstract][Full Text] [Related]
29. (1)H-MRS in glutaric aciduria type 1: impact of biochemical phenotype and age on the cerebral accumulation of neurotoxic metabolites.
Harting I; Boy N; Heringer J; Seitz A; Bendszus M; Pouwels PJ; Kölker S
J Inherit Metab Dis; 2015 Sep; 38(5):829-38. PubMed ID: 25860816
[TBL] [Abstract][Full Text] [Related]
30. Acute renal proximal tubule alterations during induced metabolic crises in a mouse model of glutaric aciduria type 1.
Thies B; Meyer-Schwesinger C; Lamp J; Schweizer M; Koeller DM; Ullrich K; Braulke T; Mühlhausen C
Biochim Biophys Acta; 2013 Oct; 1832(10):1463-72. PubMed ID: 23623985
[TBL] [Abstract][Full Text] [Related]
31. Mouse lysine catabolism to aminoadipate occurs primarily through the saccharopine pathway; implications for pyridoxine dependent epilepsy (PDE).
Pena IA; Marques LA; Laranjeira ÂB; Yunes JA; Eberlin MN; MacKenzie A; Arruda P
Biochim Biophys Acta Mol Basis Dis; 2017 Jan; 1863(1):121-128. PubMed ID: 27615426
[TBL] [Abstract][Full Text] [Related]
32. Recommendations for diagnosing and managing individuals with glutaric aciduria type 1: Third revision.
Boy N; Mühlhausen C; Maier EM; Ballhausen D; Baumgartner MR; Beblo S; Burgard P; Chapman KA; Dobbelaere D; Heringer-Seifert J; Fleissner S; Grohmann-Held K; Hahn G; Harting I; Hoffmann GF; Jochum F; Karall D; Konstantopoulous V; Krawinkel MB; Lindner M; Märtner EMC; Nuoffer JM; Okun JG; Plecko B; Posset R; Sahm K; Scholl-Bürgi S; Thimm E; Walter M; Williams M; Vom Dahl S; Ziagaki A; Zschocke J; Kölker S
J Inherit Metab Dis; 2023 May; 46(3):482-519. PubMed ID: 36221165
[TBL] [Abstract][Full Text] [Related]
33. The unsolved puzzle of neuropathogenesis in glutaric aciduria type I.
Jafari P; Braissant O; Bonafé L; Ballhausen D
Mol Genet Metab; 2011 Dec; 104(4):425-37. PubMed ID: 21944461
[TBL] [Abstract][Full Text] [Related]
34. GAI - distinct genotype and phenotype characteristics in reported Slovak patients.
Lisyova J; Petrovic R; Jurickova K; Brennerova K; Urbanova D; Behulova D; Bzduch V; Chandoga J
Bratisl Lek Listy; 2016; 117(11):631-638. PubMed ID: 28125888
[TBL] [Abstract][Full Text] [Related]
35. Disturbance of the glutamatergic system by glutaric acid in striatum and cerebral cortex of glutaryl-CoA dehydrogenase-deficient knockout mice: possible implications for the neuropathology of glutaric acidemia type I.
Busanello EN; Fernandes CG; Martell RV; Lobato VG; Goodman S; Woontner M; de Souza DO; Wajner M
J Neurol Sci; 2014 Nov; 346(1-2):260-7. PubMed ID: 25241940
[TBL] [Abstract][Full Text] [Related]
36. The long-term treatment of a patient with type 1 diabetes mellitus and glutaric aciduria type 1: the effect of insulin.
Del Rizzo M; Galderisi A; Celato A; Furlan F; Giordano L; Cazzorla C; Fasan I; Moretti C; Zschocke J; Burlina AB
Eur J Pediatr; 2016 Aug; 175(8):1123-8. PubMed ID: 26847429
[TBL] [Abstract][Full Text] [Related]
37. DHTKD1 and OGDH display substrate overlap in cultured cells and form a hybrid 2-oxo acid dehydrogenase complex in vivo.
Leandro J; Dodatko T; Aten J; Nemeria NS; Zhang X; Jordan F; Hendrickson RC; Sanchez R; Yu C; DeVita RJ; Houten SM
Hum Mol Genet; 2020 May; 29(7):1168-1179. PubMed ID: 32160276
[TBL] [Abstract][Full Text] [Related]
38. Rescue of glutaric aciduria type I in mice by liver-directed therapies.
Barzi M; Johnson CG; Chen T; Rodriguiz RM; Hemmingsen M; Gonzalez TJ; Rosales A; Beasley J; Peck CK; Ma Y; Stiles AR; Wood TC; Maeso-Diaz R; Diehl AM; Young SP; Everitt JI; Wetsel WC; Lagor WR; Bissig-Choisat B; Asokan A; El-Gharbawy A; Bissig KD
Sci Transl Med; 2023 Apr; 15(692):eadf4086. PubMed ID: 37075130
[TBL] [Abstract][Full Text] [Related]
39. Cerebral haemodynamics in patients with glutaryl-coenzyme A dehydrogenase deficiency.
Strauss KA; Donnelly P; Wintermark M
Brain; 2010 Jan; 133(Pt 1):76-92. PubMed ID: 20032085
[TBL] [Abstract][Full Text] [Related]
40. Dietary practices in glutaric aciduria type 1 over 16 years.
Gokmen-Ozel H; MacDonald A; Daly A; Ashmore C; Preece MA; Hendriksz C; Vijay S; Chakrapani A
J Hum Nutr Diet; 2012 Dec; 25(6):514-9. PubMed ID: 22845646
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
